09:57 AM EST - HLS Therapeutics Inc. : Has entered into a Product Listing Agreement (PLA) with the province of British Columbia ("BC"), for the listing and public reimbursement of Vascepa (icosapent ethyl). The PLA with BC PharmaCare is effective February 6. HLS Therapeutics Inc.
shares V.HLS are trading down $0.02 at $4.26.
